STORM Therapeutics to present the discovery of lead clinical candidate STC-15 at the American Chemical Society Fall 2023 Conference

/PRNewswire/ -- STORM Therapeutics Ltd. (STORM), a clinical stage biotechnology company focused on discovering and developing novel small molecule therapies...

Related Keywords

United States ,California ,Cambridge ,Cambridgeshire ,United Kingdom ,San Francisco ,American ,Beth Thomas ,Jerry Mcmahon ,Oliver Rausch ,Seroba Life Sciences ,Cambridge Innovation Capital ,Therapeutics Ltd ,Storm Therapeutics Ltd ,Taiho Ventures ,Moscone Center ,American Chemical Society ,Ip Group ,Utokyo Innovation Platform Co Ltd ,Fast Track Initiative ,Vice President Medicinal Chemistry ,Chief Scientific Officer ,Chief Executive Officer ,Pfizer Ventures ,Cambridge Innovation Capitali Limited ,Storm Therapeutics ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Clinical Trials Amp Medical Discoveries ,